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reast cancer is an abnormal growth of the 
glandular breast tissue and it occurs in both 
males and females.B
It is an ancient disease and has been mentioned in 
almost every period of recorded history. Ancient 
Egyptians were the first to note the disease more than 
3,500 years ago and concluded that there was no 
absolute cure.
Hippocrates in 450B.C described breast cancer as a 
1humoral disease .This theory was carried on by Galen 
in 200A.D who also described some pharmacological 
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ABSTRACT
INTRODUCTION
agents to manage its symptoms such as opium, castor 
oil, licorice, sulphur as well as incantations to the 
gods. It was not until doctors achieved greater 
thunderstanding of the circulatory system in the 17  
century that they could establish a link between breast 
2cancer and lymph nodes in the axilla . The French 
Surgeon Jean Louis Petit and later the Scottish Surgeon 
Benjamin Bell were the first to remove the lymph 
nodes, breast tissue and underlying chest muscle for 
breast cancer patients. Their successful work was 
carried on by William Stewart Halsted who started 
performing mastectomies in 1882 and his procedure 
2became known as Halsted Radical Mastectomy . This 
procedure remained popular in the surgical 
management of breast cancer up to the 1970s, when a 
new understanding of metastasis led to perceiving 








Carcinoma of the breast is a major and important form 
of malignancy worldwide with an estimated annual 
incidence of about one million cases worldwide, with 
two hundred thousand in the United States and three 
15-17hundred and twenty thousand cases in Europe .The 
incidence of breast cancer is rising in population 
groups that hitherto enjoyed a low incidence. In 
Nigeria for example, the incidence rate rose from 13.8 – 
15.3 per 100,000 in the 1980s to 33.6 per 100,000 in 
9  1992, and 116 per 100,000 in 2000 . Prior to the 
increase in incidence, it was believed that there was 
under-reporting owing to low awareness, poor access 
to medical facilities, poverty, socio-cultural factors and 
18  absence of breast screening programmes .
Between 1960 and 1980, the cancer registry of 
University College Hospital, Ibadan recorded 17,496 
and more sparing procedures were developed that 
proved equally effective.
Carcinoma of the breast is the leading malignancy 
affecting women and the commonest cause of cancer 
3-5mortality worldwide . Incidence rates are higher in 
developed countries while they are low but increasing 
6-8in developing countries . This variation may be due 
to demographic factors such as longer life expectancy, 
better reporting and awareness of the disease, and 
improved access to clinical care seen in developed 
9-10countries . Genetic factors are also considered to 
 11contribute to the differences in incidence .
In Africans generally, carcinoma of the breast tends to 
present at a relatively younger age, with larger 
tumours, multiple nodal involvement and poorer 
clinical and pathological prognostic factors compared 
12-14with Caucasian patients . The aim of this review is 
to update and summarize the predisposing factors of 
breast cancer.
cases of cancer with breast cancer being the fourth 
commonest cancer overall and the second commonest 
in women. However, between 1980 and 1989, it had 
19become the commonest malignancy . 
The cause of breast cancer is unknown, but certain 
risk factors have been identified to predispose to 
increased susceptibility to the disease. These risk 
factors include:
GENDER:    It is a disease of women with less than 
1% being males20. A retrospective study conducted in 
Pakistan and published in 2006 observed carcinoma of 
the breast affecting males in 5.9% of all cases and a 
21  male to female ratio of 1:16 .
Muguti in Zimbabwe observed over a 31/2 year 
period that only 2% of patients with carcinoma of the 
22breast were males . The annual incidence in 
Zimbabwe is 14 per 100,000 for females and 0.4 per 
22100,000 for males . Anyanwu observed a male to 
female ratio of 1:67 in a 10 year review from Eastern 
23  Nigeria .  
AGE: Carcinoma of the breast is rare below the age of 
20 years but thereafter the incidence steadily rises so 
that by the age of 90 years nearly 20% of women are 
 24affected .
The incidence in Africa peaks between ages 35 and 45, 
approximately 10-15 years earlier than the peak 
23,25-27incidence for western countries  and it is 
suggested to be due to the lower life expectancy (46 
years for Nigerian women; World Health Statistics 
2006) and the younger population age in this 
9  22environment .A study from Zimbabwe  reported a 
second but smaller increase in incidence occurring 
between the ages of 60 and 69 years. Adebamowo and 
19 Adekunle in a prospective study in1999 observed a 
mean age of 43 years in breast cancer patients which is 
similar to previous observations from other centers in 
22,26-27Africa .
PREVIOUS BREAST CANCER:  The risk of contra 
lateral breast cancer was about five times that in the 
28-29general female population. Some other studies  
have confirmed the higher risk of women who have 
previously had one breast cancer. The development of 
a second breast cancer may be a clinical manifestation 
of a multifocal origin of the first cancer or may be an 
entirely new cancer. Robbins and Bergs in 1964 
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RESULTS
The cause of breast cancer is unknown but 
predisposing factors (of which various researchers 
reported their experiences) have been identified to 
indicate increase susceptibility to the disease. 
DISCUSSION
prospectively followed up 1458 women who had 
ipsilateral breast cancer treated by radical 
mastectomy. Ninety four new primary contra lateral 
breast cancers were found during a follow up period of 
20 years.
30  FAMILY HISTORY:   This is a strong risk factor .
Handerson and Pike, and Lynch and Marcus have 
documented the importance of hereditary and genetic 
31, 32predisposition to cancer of the breast . In a study by 
Lynch and Marcus of 328 patients, 68% were sporadic, 
2 3 %  w e r e  f a m i l i a l ,  a n d  9 %  w e r e  
32hereditary .Definitions suggested by Lynch and 
Marcus are as follows:
A)  Sporadic breast cancer: a patient with cancer of 
the breast with no family history of cancer of the 
breast through 2 generations involving siblings, 
offspring, parents, aunts, uncles and both sets of 
grandparents.
B) Familial breast cancer: A patient with cancer of the 
breast with a family history including one or more 
st nd1  or 2  degree relative with breast cancer that does 
not fit the hereditary breast cancer definition.
C)  Hereditary breast cancer:   A patient with cancer 
of the breast with a positive family history of 
breast cancer and sometimes related cancer such as 
ovarian or colonic cancers. There is early age at 
premenopausal onset, increased incidence of 
bilateral breast cancer and multiple primary 
cancers. It is inherited as an autosomal dominant 
trait. 
Linkage to BRCA 1 gene is present in most patients 
with hereditary breast cancer and this gene is mapped 
to a region of the chromosome 17q. BRCA 2 gene was 
mapped to the q 12-13 region of chromosome 13 and 
is linked to most families with male hereditary breast 
cancer.
A summary of studies before 1963 on familial 
aggregation of breast cancer indicated that female 
relatives of women with breast cancer have 2 or 3 
33times the general populations' breast cancer rate . 
This increased risk appears as great for paternal 
33,34relatives as those on the maternal side . It has been 
reported that 5 - 10% (9000-18,000 cases per year in 
USA) of women who develop breast cancer does so 
35   because of an inheritable predisposition . Dumetriscu 
and Cotarla found that women with one, two and 
three or more first degree relatives have an increased 
breast cancer risk when compared to women who do 
36not have an affective relative . Adebamowo and 
Adekunle in 1999 found only 2% of breast cancer 
patients with a positive family history in a prospective 
study involving 250 patients with breast cancer at 
19Ibadan . It was also observed that family history of 
breast cancer was difficult to elicit in Ibadan for several 
reasons such as lack of proper records, fear of 
stigmatization, low life expectancy and social 
37 19taboos , all of which contribute to the lack of data . A 
study from Zimbabwe observed family history in 6% 
22of patients .
NULLIPARITY:  This increases the risk of developing 
15breast cancer . With increasing age at the time of first 
pregnancy, the risk increases proportionately. Women 
who have their first full term pregnancy before the age 
rdof 18 have a lower risk, about 1/3  that of women 
15with first pregnancy over 35 years . This relative 
increased risk in the latter group is speculated to be due 
to persistent exposure to endogenous oestrogens in the 
absence of appropriate concentration of progesterone. 
38Rosenberg et al  evaluated breast cancer risk in 
relation to parity among South African women and 
found an association between nulliparity and breast 
cancer. 
38AGE AT FIRST PREGNANCY:  Rosenberg et al  
observed that women who had their first child at 30 
years or older, had a 2-fold increase in breast cancer 
risk compared to women who had their first child at 
3818 years or younger . In another study in South 
Africa, women who developed breast cancer had an 
older age at first birth and a higher level of education 
39compared to control group . Oestriol is non 
carcinogenic whereas oestrone and oestrodiol have 
been shown to be carcinogenic. During pregnancy, 
oestriol production increases proportionately over the 
40production of carcinogenic oestrogen . Subsequent 
40pregnancies are believed to have much less effect .
AGE AT MENARCHE AND MENOPAUSE: Women 
who attained menarche before the age of 12 years have 
an increased risk compared to those whose menarche 
is after this age. Several studies have highlighted the 
role of prolonged exposure to endogenous oestrogen 
41-43as a risk factor of breast carcinoma .Early 
menarche, late menopause, low parity, older age at 
first full term pregnancy are all associated with a 
9
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higher risk of breast cancer.
Age at menarche decreases while that of menopause 
increases and therefore increase incidence observed as a 
society gets more affluent and living standard 
 44improves .
However in the study by Adebamowo and Adekunle, 
the mean age at menarche in both study and control 
19groups was about 15 years .In another study of 
nearly 2000 African cancer patients reported by 
Ihekwaba at Ibadan, he also did not identify any 
correlation between breast cancer risk and parity, risk 
 45and age at menarche or risk and lactation .
IRRADIATION: Women exposed to irradiation 
especially during high mitotic activities (e.g. 
pregnancy, menarche) have an increased risk of 
developing cancer of the breast. An increased risk has 
also been observed in women treated by irradiation for 
post partum mastitis and patients receiving multiple 
chest radiographs during assessment of pulmonary 
46tuberculosis . This increased risk became apparent 
after a latent period of 10-15 years. Mackenzie in 
1965 reported an increased risk for women 
undergoing repeated f luoroscopy dur ing 
pneumothorax treatment for pulmonary 
tuberculosis.A subsequent report has confirmed this 
47increased risk following multiple fluoroscopy  and 
also following radiation therapy for acute post 
47partum mastitis .
48A report from atomic bomb casualty commission  
showed that the breast is more susceptible to 
carcinogenic effect of ionizing radiation during 
periods of high mitotic activities such as pregnancy 
48and at menarche .
OBESITY: This is associated with an increased risk of 
breast cancer especially in post menopausal patients. 
In a case control study from Ibadan by Adebamowo et 
al involving 234 breast cancer patients, it was 
observed that postmenopausal obesity was associated 
with breast cancer risk when measured as a function 
49of waist- hip ratio . Another analysis of the same 
population also demonstrated this association when 
obesity was estimated by body mass index (BMI) to be 
greater than 30. 
DIET:  There is experimental evidence to suggest that 
high fat diet in rats and mice is associated with an 
increase in the number of breast tumours in these 
animals. The exact mechanism of this risk is not 
known. However, no definitive evidence is available to 
associate high fat diet with breast cancer in humans. A 
popular suggestion is that fat contains some pro-
carcinogens which are simply converted to 
carcinogens on ingestion. The increasing 
consumption of high fat diet in some countries with 
previously low incidence like Japan has been linked to 
50rising incidence of breast cancer . A typical diet in 
Africa consists mainly of grains, vegetables and fibre 
51with little fat or protein. In studies by Djuric  and 
52Boyd , it was suggested that this nutritional intake 
pattern may be protective against breast cancer. 
Physiologically relevant concentrations of a potential 
chemo-protective agent (by means of dose dependent 
inhibition of DNA synthesis) have been identified in at 
least one vegetable, veronia amycdalina that is 
 53consumed heavily in West Africa .
ORAL CONTRACEPTIVE PILLS: There is a slightly 
increased risk of developing breast cancer in women 
who take oestrogen based oral contraceptive pills. In 
19the study by Adebamowo and Adekunle  at Ibadan, it 
was observed that 4% of patients with breast cancer 
had used oral contraceptive pills compared to 0.8% of 
control. Some researchers believe that intake of oral 
contraceptive pills does not predispose to the 
development of breast cancer. A study of about 4575 
women between 35 and 64 years of age with breast 
cancer when compared to about 4682 control did not 
detect any association between breast cancer and oral 
54contraceptive use .
BENIGN BREAST DISEASE:  Mult ip l e  
papillomatosis may be regarded as a risk factor of 
carcinoma of the breast. Anyanwu studied breast 
cancer from 4 hospitals in Eastern Nigeria and found 
out that 12% of patients reported a prior history of 
23benign breast disease . Haagensen reported the 
follow-up results of his patients with gross cystic 
disease and multiple intraductal papillomata. He 
found that the ratio of observed to expected 
subsequent cancers in patients with gross cystic 
disease is 3:1 and 4:1 for multiple intraductal 
papilloma. He followed up his patients for about 5 – 
10 years. This stresses the importance of subjecting 
every breast lump to biopsy, submitting any biopsy 
specimen for histology and a good follow- up 
55programme for the patients .
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BREAST FEEDING: This decreases the life time 
incidence of breast cancer by decreasing the 
cumulative number of ovulating menstrual cycles. 
39Coogan and colleagues  evaluated breast cancer risk 
related to lactation among South African women and 
postulated that lactation causes differentiation of 
ductal epithelial cells which is protective against 
carcinogens. However, some other earlier studies had 
indicated little or no difference in the lactation 
56, 57experience of breast cancer patients and controls . 
Most of these studies were in countries with high 
breast cancer rates.
ALCOHOL: This has been found to be a risk factor for 
58breast cancer . The primary mechanism may be 
58attributed to increased oestrogen level . A study of 
more than one million middle aged British women 
concluded that each daily alcoholic beverage increases 
the incidence of breast cancer by 11 cases per 1000 
59women .   
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Breast cancer is the commonest malignancy affecting 
women worldwide. It is commoner in developed 
countries but with increasing incidence in developing 
countries. The peak age incidence in developing 
countries is one to two decades lower than that in 
developed countries.
CONCLUSION
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